Alternatives to GenSight Biologics
GenSight Biologics is a Biotechnology tool: developing innovative gene therapies to preserve or restore vision in patients with retinal diseases. Here are the 54 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to GenSight Biologics
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
Alnylam PharmaceuticalsNot ratedBiopharmaceutical company pioneering RNA interference (RNAi) therapeutics to treat rare and prevalent genetic diseases.
Ray TherapeuticsNot ratedPioneering vision restoration therapies for severe retinal degenerations.
Epicrispr BiotechnologiesNot ratedEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Rocket PharmaceuticalsNot ratedA biotechnology company developing genetic therapies for rare disorders.
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Arc InstituteNot ratedA nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.
Verve TherapeuticsNot ratedDeveloping gene editing therapies to lower cholesterol.
Latus BioNot ratedEngineering scalable gene therapies for broader patient populations.
SonoTheraNot ratedDeveloping ultrasound-mediated nonviral genetic medicines.
Immitra BioNot ratedScalable, one-time curative in-vivo gene editing therapies.
Generate Biomedicines3.0 out of 5 (1)AI-driven biotechnology company developing novel protein therapeutics through generative biology.
Laverock TherapeuticsNot ratedDeveloping disease-responsive advanced therapies through programmable gene control technology.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Estuary BiotherapeuticsNot ratedBiotechnology company developing genetic medicines for patients with serious kidney diseases, focusing on autosomal dominant polycystic kidney disease (ADPKD).
Kite PharmaNot ratedBiotechnology company developing and commercializing cell therapies for cancer treatment.
BioNTechNot ratedGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
- JUJuno TherapeuticsNot rated
Biotechnology company focused on developing cancer immunotherapies.
CRISPR TherapeuticsNot ratedBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Mammoth BiosciencesNot ratedBiotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
Showing the next 20 closest matches. See the rest on the GenSight Biologics profile.
Sponsored rows are paid and labelled. Advertise on this page
